Oxidative modification of glutamine synthetase by amyloid beta peptide

Free Radical Research

Volumn 27, Issue 3, 1997, Pages 267-281

  Aksenov, Michael Y ^a   Aksenova, Marina V ^a   Carney, John M ^a   Butterfield, D Allan ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Amyloid peptide; Glutamine synthetase; Inactivation; Protein carbonyls

Indexed keywords

AMYLOID BETA PROTEIN; CELL PROTEIN; FREE RADICAL; GLUTAMATE AMMONIA LIGASE; IRON; PEROXIDE;

ALZHEIMER DISEASE; AQUEOUS SOLUTION; ARTICLE; CONTROLLED STUDY; ENZYME INACTIVATION; NERVE CELL CULTURE; OXIDATION; OXIDATIVE STRESS; SENILE PLAQUE;

EID: 0030657456     PISSN: 10715762     EISSN: None     Source Type: Journal    
DOI: 10.3109/10715769709065765     Document Type: Article

References (48)

1. Selkoe, D. J. (1991). The molecular pathology of Alzheimer's disease. Neuron, 6, 487-498.
2. Roher, A. E., Lowenson, J. D., Clarke, S., Wood, A. S., Cotter, R. J., Gowing, E., Ball, M. J. (1993). β-Amyloid (1-42) is a major component of cerebrovascular amyloid deposits: implications for the pathology of Alzheimer's disease. Proceedings of the National Academy of Science of the USA, 90, 10836-10840.
3. Fukumoto, H., Asami-Odaka, A., Suzuki, N., Shimada, H., Ihara, Y., Iwatsubo, T. (1996). Amyloid β protein deposition in normal aging has the same characteristics as that in Alzheimer's disease. Predominance of Aβ42(43) and association of Aβ40 with cored plaques. American Journal of Pathology, 148, 259-265.
4. Frautschy, S. A., Baird, A., Cole, G. M. (1991). Effects of injected Alzheimer's β-amyloid cores in rat brain. Proceedings of the National Academy of Science of the USA, 88, 8362-8366.
5. Kowall, N. W., Beal, M. F., Busciglio, J., Duffy, L. K., Yankner, B. (1991). An in vivo model for the neurodegenerative effects of β-amyloid and protection by substance P. Proceedings of the National Academy of Science of the USA, 88, 7247-7251.
6. May, P. C., Gitter, B. D., Waters, D. C., Simmons, L. K., Becker, G. W., Small, J. S., Robinson, P. M. (1992). β-Amyloid peptide in vitro toxicity: lot-to-lot variability. Neurobiology of Aging, 13, 605-607.
7. Pike, C. J., Burdick, D., Walencewicz, A. J., Glabe, C. G., Cotman, C. W. (1993). Neurodegeneration induced by β-amyloid peptides in vitro: the role of peptide assembly state. Journal of Neuroscience, 13, 1676-1687.
8. Simmons, L. K., May, P. C., Tomaselli, K. J., Rydel, R. E., Fuson, K. S., Brigham, E. F., Wright, S., Lieburg, I., Becker, G. W., Brems, D. N., Li, W. Y. (1994). Secondary structure of amyloid β peptide correlates with neurotoxic activity in vitro. Molecular Pharmacology, 45, 373-379.
9. Lorenz, A. and Yankner, B. A. (1994). β-Amyloid neurotoxicity requires fibril formation and is inhibited by Congo red. Proceedings of the National Academy of Science of the USA, 91, 12243-12247.
10. Harris, M. E., Hensley, K., Butterfield, D. A., Leedle, R. A., Carney, J. M. (1995). Direct evidence of oxidative injury produced by the Alzheimer's amyloid beta-peptide (1-40) in cultured hippocampal neurons. Experimental Neurology, 131, 193-202.
11. Pike, C. J., Walcncewicz-Wasserman, A. J., Kosmoski, J., Cribbs, D. H., Glabe, C. G., Cotman, C. W. (1995). Structure-activity analyses of β-amyloid peptides: contribution of the β25-35 region to aggregation and neurotoxicity. Journal of Neurochemistry, 64, 253-265.
12. Hensley, K., Carney, J. M., Mattson, M. P., Aksenova, M. V., Harris, M. E., Wu, J. F., Floyd, R. A., Butterfield, D. A. (1994). A model for β-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer's disease. Proceedings of the National Academy of Science of the USA, 91, 3270-3274.
13. Hensley, K., Aksenova, M., Carney, J. M., Harris, M., Butterfield, D. A. (1995). Amyloid β-peptide spin trapping 1: peptide enzyme toxicity is related to free radical spin trap reactivity. Neuroreport, 6, 489-492.
14. Hensley, K., Aksenova, M., Carney, J. M., Harris, M., Butterfield, D. A. (1995). Amyloid β-peptide spin trapping II: evidence for decomposition of the PBN spin adduct. Neuroreport, 6, 489-492.
15. Mason, R. P., Estermyer, J. D., Kelly, J. F., Mason, P. E. (1996). Alzheimer's disease amyloid β peptide 25-35 is localized in the membrane hydrocarbon core: X-ray diffraction analysis. Biochemical and Biophysical Research Communications, 222, 78-82.
16. Butterfield, D. A., Hensley, K., Harris, M., Mattson, M., Carney, J. M. (1994). β-Amyloid peptide free radical fragments initiate synaptosomal lipoperoxidation in a sequence specific fashion: implications to Alzheimer's disease. Biochemical and Biophysical Research Communications, 200, 710-715.
17. Mattson, M. P., Cheng, B., Davis, D., Bryant, K., Lieberburg, I., Rydel, R. E. (1992). β-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity. Journal of Neuroscience, 12, 376-389.
18. Mark, R., Hensley, K., Butterfield, D. A., Mattson, M. (1995). Amyloid β-peptide impairs ion-motive ATPase activities: evidence for a role in loss of neuronal Cahomeostasis and cell death. Journal of Neuroscience, 15, 6239-6249.
19. Harris, M. E., Wang, Y., Pedigo, N. W., Hensley, K., Butterfield, D. A., Carney, J. M. (1996). Amyloid β peptide (25-35) inhibits Na-dependent glutamate uptake in rat hippocampal astrocyte cultures, Journal of Neurochemistry, 67, 277-286.
20. Butterfield, D. A., Hensley, K., Hall, N., Subramaniam, R., Howard, B., Cole, P., LaFontaine, M., Harris, M. E., Aksenova, M. V., Aksenov, M. Y., Carney, J. M. (1996). Beta-amyloid-derived free radical oxidation: a fundamental process in Alzheimer's disease. In: Molecular Models of Dementia (Eds. Tanzi R. E. and Wasco W.) Humana Press, N. J.
21. Levine, R. L., Garland, D., Oliver, C. N., Amici, A., Climent, I., Lenz, A.-G., Ahn, B.-W., Shaltiel, S., Stadtman, E. R. (1990). Determination of carbonyl content in oxidatively modified proteins. Methods in Enzymology, 186, 464-487.
22. Levine, R. L., Williams, J. A., Stadtman, E. R., Stadman, Shacter, E. (1994). Carbonyl assays for determination of oxidatively modified proteins. Methods in Enzymoloy, 233, 346-357.
23. Martinez-Hernandez, A., Bell, K. P., Norenberg, M. D. (1976). Glutamine synthetase: glial localization in brain. Science, 195, 1356-1358.
24. Norenberg, M. D. (1982). Immunohistochemical study of glutamine synthetase in brain trauma. Journal of Neuropathology and Experimental Neurology, 41, 347.
25. Oliver, C. N., Starke-Reed, P. E., Stadtman, E. R., Liu, G. J., Carney, J. M., Floyd, R. A. (1990). Oxidative damage to brain proteins, loss of glutamine synthetase activity, and production of free radicals during ischemia/reperfusion-induced injury to gerbril brain. Proceedings of the National Academy of Science of the USA, 87, 5144-5147.
26. Smith, C. D., Carney, J. M., Starke-Reed, P. E., Oliver, C. N., Stadtman, E. R., Floyd, R. A., Markesbery, W. R. (1991). Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer's disease. Proceedings of the National Academy of Science of the USA, 88, 10540-10543.
27. Tanaka, H., Araki, M., Masuzawa, T. (1992). Reaction of astrocytes in the gerbil hippocampus following transient ischemia: immunohistochemical observations with antibodies against glial fibrillary acidic protein, glutamine synthetase, and S-100 protein. Experimental Neurology, 116, 264-274.
28. Le Prince, G., Delaere, P., Fages, C., Lefrancois, T., Touret, M., Salanon, M., Tardy, M. (1995). Glutamine Synthetase expression is reduced in senile dementia of the Alzheimer's type. Neurochemical Research, 20, 859-862.
29. Oliver, C. N., Ahn, B. W., Moerman, E. J., Boldstein, S., Stadtman, E. R. (1987). Age-related changes in oxidized proteins, Journal of Biological Chemistry, 262, 5488-5491.
30. Fisher, M. T. and Stadtman, E. R. (1992). Oxidative modification of Escherichia coli glutamine synthetase. Journal of Biological Chemistry, 267, 1872-1880.
31. Rowe, W. B., Remzio, R. A., Wellner, V. P., Meister, A. (1970). Glutamine synthetase (sheep brain). Methods in Enzymology, 17, 900-910.
32. Miller, R. E., Hadenberg, R., Gersham, H. (1978). Regulation of glutamine synthetase in cultured 3T3-L1 cells by insulin, hydrocortisone, and dibutyryl cyclic AMP. Proceedings of the National Academy of Science of the USA, 75, 1418-1422.
33. Aksenov, M. Y., Aksenova, M. V., Harris, M. E., Hensley, K., Butterfield, D. A., Carney, J. M. (1995). Enhancement of β-amyloid peptide Aβ(1-40)-mediated neurotoxicity by glutamine synthetase. Journal of Neurochemistry, 65, 1899-1902.
34. Laemmli, U. K. (1970). Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature, 227, 680.
35. Glenney, J. R. (1986). Antibody probing on Western blots have been stained with India ink. Analytical Biochemistry, 156, 315-318.
36. Butterfield, D. A., Hensley, K., Cole, P., Aksenov, M., Aksenova, M., Bummer, P. M., Carney, J. M., Haley, B. E. (1997). Oxidatively-induced structural alterations of glutamine synthetase assessed by analysis of spin label incorporation kinetics: relevance to Alzheimer's disease. Journal of Neurochemistry, 68, 2451-2457.
37. Aksenov, M. Y., Aksenova, M. V., Butterfield, D. A., Hensley, K., Vigo-Pelfrey, C., Carney, J. M. (1996). Glutamine synthetase-induced enhancement of β-Amyloid peptide Aβ(1-40) neurotoxicity accompanied by abrogation of fibril formation and Aβ fragmentation. Journal of Neurochemistry, 66, 2050-2056.
38. Rivett, A. J. and Levine, R. L. (1990). Metal-catalyzed oxidation of Esclu'richia call glutamine synthetase: correlation of structural and functional changes. Archives of Biochemistry and Biophysics, 278, 26-34.
39. Schubert, D. and Chevion, M. (1995). The role of iron in beta amyloid toxicity. Biochemical and Biophysical Research Communications, 216, 702-707.
40. Davies, M. J., Fu, S., Dean, R. T. (1995). Protein hydroperoxides can give rise to reactive free radicals. Biochemical Journal, 305, 643-649.
41. Van Rensburg, S. J., Carstens, M. E., Potocnik, F. C., van der Spuy, G., van der Walt, B. J., Taljaard, J. J. (1995). Transferrin C2 and Alzheimer's disease: another piece of the puzzle found? Medical Hypotheses, 44, 268-272.
42. Amici, A., Levine, R. L., Tsai, L., Stadtman, E. R. (1989). Conversion of amino acid residues in proteins and amino acid homopolymers to carbonyl derivates by metal-catalyzed oxidation reactions. Journal of Biological Chemistry, 264, 3341-3346.
43. Hensley, K., Hall, N., Subramanian, R., Cole, P., Harris, M., Aksenov, M., Aksenova, M., Gabbita, P., Wu, J., Carney, J., Lowell, M., Markesbery, W. R., Butterfield, D. A. (1995). Brain regional correspondence between Alzheimer's disease histopathology and biomarkers of protein oxidation. Journal of Neurochemistry, 65, 2146-2156.
44. Tumani, H., Shen, G. Q., Peter, J. B. (1995). Purification and immunocharacterization of human brain glutamine synthetase and its detection in cerebrospinal fluid and serum by a sandwich enzyme immunoassay. Journal of Immunological Methods, 188, 155-163.
45. Gunnersen, D. and Haley, B. (1992). Detection of glutamine synthetase in the cerebrospinal fluid of Alzheimer diseases patients: a potential diagnostic marker. Proceedings of the National Academy of Science of the USA, 89, 11949-11953.
46. Friedlich, A. and Butcher, L. (1994). Involvement of free oxygen radicals in β-amyloidosis: an hypothesis. Neurobiology of Aging, 15, 443-455.
47. Schubert, D., Behl, C., Lesley, R., Brack, A., Dargusch, R., Sagara, Y., Kimura, H. (1995). Amyloid peptides are toxic via a common oxidative mechanism. Proceedings of the National Academy of Sciences of the USA, 92, 1989-1993.
48. Hensley, K., Butterfield, D. A., Hall, N., Cole, P., Subramaniam, R., Mark, R., Mattson, M., Markesbery, W. R., Harris, M. E., Aksenov, M., Aksenova, M., Wu, J., Carney, J. M. (1996). Reactive oxygen species as causal agents in the neurotoxicity of the Alzheimer's disease-associated amyloid beta peptide. Annals of the New York Academy of Sciences, 786, 120-134.